Transmucosal Drug Delivery Market - Global Outlook and Forecast 2021-2027

Transmucosal Drug Delivery Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Transmucosal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transmucosal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transmucosal Drug Delivery Overall Market Size
2.1 Global Transmucosal Drug Delivery Market Size: 2021 VS 2027
2.2 Global Transmucosal Drug Delivery Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transmucosal Drug Delivery Players in Global Market
3.2 Top Global Transmucosal Drug Delivery Companies Ranked by Revenue
3.3 Global Transmucosal Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Transmucosal Drug Delivery Companies in Global Market, by Revenue in 2020
3.5 Global Companies Transmucosal Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transmucosal Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Transmucosal Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transmucosal Drug Delivery Market Size Markets, 2021 & 2027
4.1.2 Passive Transdermal Drug Delivery
4.1.3 Active Transdermal Drug Delivery
4.2 By Type - Global Transmucosal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Transmucosal Drug Delivery Revenue, 2016-2021
4.2.2 By Type - Global Transmucosal Drug Delivery Revenue, 2022-2027
4.2.3 By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transmucosal Drug Delivery Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Transmucosal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Transmucosal Drug Delivery Revenue, 2016-2021
5.2.2 By Application - Global Transmucosal Drug Delivery Revenue, 2022-2027
5.2.3 By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Transmucosal Drug Delivery Market Size, 2021 & 2027
6.2 By Region - Global Transmucosal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Transmucosal Drug Delivery Revenue, 2016-2021
6.2.2 By Region - Global Transmucosal Drug Delivery Revenue, 2022-2027
6.2.3 By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Transmucosal Drug Delivery Revenue, 2016-2027
6.3.2 US Transmucosal Drug Delivery Market Size, 2016-2027
6.3.3 Canada Transmucosal Drug Delivery Market Size, 2016-2027
6.3.4 Mexico Transmucosal Drug Delivery Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Transmucosal Drug Delivery Revenue, 2016-2027
6.4.2 Germany Transmucosal Drug Delivery Market Size, 2016-2027
6.4.3 France Transmucosal Drug Delivery Market Size, 2016-2027
6.4.4 U.K. Transmucosal Drug Delivery Market Size, 2016-2027
6.4.5 Italy Transmucosal Drug Delivery Market Size, 2016-2027
6.4.6 Russia Transmucosal Drug Delivery Market Size, 2016-2027
6.4.7 Nordic Countries Transmucosal Drug Delivery Market Size, 2016-2027
6.4.8 Benelux Transmucosal Drug Delivery Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Transmucosal Drug Delivery Revenue, 2016-2027
6.5.2 China Transmucosal Drug Delivery Market Size, 2016-2027
6.5.3 Japan Transmucosal Drug Delivery Market Size, 2016-2027
6.5.4 South Korea Transmucosal Drug Delivery Market Size, 2016-2027
6.5.5 Southeast Asia Transmucosal Drug Delivery Market Size, 2016-2027
6.5.6 India Transmucosal Drug Delivery Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Transmucosal Drug Delivery Revenue, 2016-2027
6.6.2 Brazil Transmucosal Drug Delivery Market Size, 2016-2027
6.6.3 Argentina Transmucosal Drug Delivery Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, 2016-2027
6.7.2 Turkey Transmucosal Drug Delivery Market Size, 2016-2027
6.7.3 Israel Transmucosal Drug Delivery Market Size, 2016-2027
6.7.4 Saudi Arabia Transmucosal Drug Delivery Market Size, 2016-2027
6.7.5 UAE Transmucosal Drug Delivery Market Size, 2016-2027
7 Players Profiles
7.1 3M Pharmaceuticals
7.1.1 3M Pharmaceuticals Corporate Summary
7.1.2 3M Pharmaceuticals Business Overview
7.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Major Product Offerings
7.1.4 3M Pharmaceuticals Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.1.5 3M Pharmaceuticals Key News
7.2 Acrux Limited
7.2.1 Acrux Limited Corporate Summary
7.2.2 Acrux Limited Business Overview
7.2.3 Acrux Limited Transmucosal Drug Delivery Major Product Offerings
7.2.4 Acrux Limited Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.2.5 Acrux Limited Key News
7.3 ALZA Corporation
7.3.1 ALZA Corporation Corporate Summary
7.3.2 ALZA Corporation Business Overview
7.3.3 ALZA Corporation Transmucosal Drug Delivery Major Product Offerings
7.3.4 ALZA Corporation Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.3.5 ALZA Corporation Key News
7.4 Antares Pharma, Inc.
7.4.1 Antares Pharma, Inc. Corporate Summary
7.4.2 Antares Pharma, Inc. Business Overview
7.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Major Product Offerings
7.4.4 Antares Pharma, Inc. Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.4.5 Antares Pharma, Inc. Key News
7.5 Apricus BioSciences, Inc
7.5.1 Apricus BioSciences, Inc Corporate Summary
7.5.2 Apricus BioSciences, Inc Business Overview
7.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Major Product Offerings
7.5.4 Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.5.5 Apricus BioSciences, Inc Key News
7.6 Aveva Drug Delivery Systems
7.6.1 Aveva Drug Delivery Systems Corporate Summary
7.6.2 Aveva Drug Delivery Systems Business Overview
7.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Major Product Offerings
7.6.4 Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.6.5 Aveva Drug Delivery Systems Key News
7.7 Corium International, Inc
7.7.1 Corium International, Inc Corporate Summary
7.7.2 Corium International, Inc Business Overview
7.7.3 Corium International, Inc Transmucosal Drug Delivery Major Product Offerings
7.4.4 Corium International, Inc Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.7.5 Corium International, Inc Key News
7.8 DURECT Corporation
7.8.1 DURECT Corporation Corporate Summary
7.8.2 DURECT Corporation Business Overview
7.8.3 DURECT Corporation Transmucosal Drug Delivery Major Product Offerings
7.8.4 DURECT Corporation Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.8.5 DURECT Corporation Key News
7.9 Generex Biotechnology Corporation
7.9.1 Generex Biotechnology Corporation Corporate Summary
7.9.2 Generex Biotechnology Corporation Business Overview
7.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Major Product Offerings
7.9.4 Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.9.5 Generex Biotechnology Corporation Key News
7.10 Inovio Pharmaceuticals, Inc.
7.10.1 Inovio Pharmaceuticals, Inc. Corporate Summary
7.10.2 Inovio Pharmaceuticals, Inc. Business Overview
7.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.10.4 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.10.5 Inovio Pharmaceuticals, Inc. Key News
7.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
7.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Summary
7.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
7.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Major Product Offerings
7.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Key News
7.12 MedPharm LTD
7.12.1 MedPharm LTD Corporate Summary
7.12.2 MedPharm LTD Business Overview
7.12.3 MedPharm LTD Transmucosal Drug Delivery Major Product Offerings
7.12.4 MedPharm LTD Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.12.5 MedPharm LTD Key News
7.13 Mylan, Inc.
7.13.1 Mylan, Inc. Corporate Summary
7.13.2 Mylan, Inc. Business Overview
7.13.3 Mylan, Inc. Transmucosal Drug Delivery Major Product Offerings
7.13.4 Mylan, Inc. Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.13.5 Mylan, Inc. Key News
7.14 Nemaura Pharma Ltd
7.14.1 Nemaura Pharma Ltd Corporate Summary
7.14.2 Nemaura Pharma Ltd Business Overview
7.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Major Product Offerings
7.14.4 Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.14.5 Nemaura Pharma Ltd Key News
7.15 Nitto Denko Corporation
7.15.1 Nitto Denko Corporation Corporate Summary
7.15.2 Nitto Denko Corporation Business Overview
7.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Major Product Offerings
7.15.4 Nitto Denko Corporation Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.15.5 Nitto Denko Corporation Key News
7.16 Noven Pharmaceuticals, Inc.
7.16.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.16.2 Noven Pharmaceuticals, Inc. Business Overview
7.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Major Product Offerings
7.16.4 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.16.5 Noven Pharmaceuticals, Inc. Key News
7.17 Pantec Biosolutions AG
7.17.1 Pantec Biosolutions AG Corporate Summary
7.17.2 Pantec Biosolutions AG Business Overview
7.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Major Product Offerings
7.17.4 Pantec Biosolutions AG Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.17.5 Pantec Biosolutions AG Key News
7.18 Tapemark
7.18.1 Tapemark Corporate Summary
7.18.2 Tapemark Business Overview
7.18.3 Tapemark Transmucosal Drug Delivery Major Product Offerings
7.18.4 Tapemark Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.18.5 Tapemark Key News
7.19 tesa Labtec GmbH
7.19.1 tesa Labtec GmbH Corporate Summary
7.19.2 tesa Labtec GmbH Business Overview
7.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Major Product Offerings
7.19.4 tesa Labtec GmbH Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.19.5 tesa Labtec GmbH Key News
7.20 TEVA Pharmaceutical Industries Ltd.
7.20.1 TEVA Pharmaceutical Industries Ltd. Corporate Summary
7.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
7.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Major Product Offerings
7.20.4 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.20.5 TEVA Pharmaceutical Industries Ltd. Key News
7.21 Zosano Pharma
7.21.1 Zosano Pharma Corporate Summary
7.21.2 Zosano Pharma Business Overview
7.21.3 Zosano Pharma Transmucosal Drug Delivery Major Product Offerings
7.21.4 Zosano Pharma Transmucosal Drug Delivery Revenue in Global (2016-2021)
7.21.5 Zosano Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Transmucosal Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Transmucosal Drug Delivery Market Drivers in Global Market
Table 3. Transmucosal Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Transmucosal Drug Delivery in Global Market
Table 5. Top Transmucosal Drug Delivery Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Transmucosal Drug Delivery Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Transmucosal Drug Delivery Revenue Share by Companies, 2016-2021
Table 8. Global Companies Transmucosal Drug Delivery Product Type
Table 9. List of Global Tier 1 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transmucosal Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Transmucosal Drug Delivery Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Transmucosal Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Transmucosal Drug Delivery Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Transmucosal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Transmucosal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Transmucosal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 30. 3M Pharmaceuticals Corporate Summary
Table 31. 3M Pharmaceuticals Transmucosal Drug Delivery Product Offerings
Table 32. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 33. Acrux Limited Corporate Summary
Table 34. Acrux Limited Transmucosal Drug Delivery Product Offerings
Table 35. Acrux Limited Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 36. ALZA Corporation Corporate Summary
Table 37. ALZA Corporation Transmucosal Drug Delivery Product Offerings
Table 38. ALZA Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 39. Antares Pharma, Inc. Corporate Summary
Table 40. Antares Pharma, Inc. Transmucosal Drug Delivery Product Offerings
Table 41. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 42. Apricus BioSciences, Inc Corporate Summary
Table 43. Apricus BioSciences, Inc Transmucosal Drug Delivery Product Offerings
Table 44. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 45. Aveva Drug Delivery Systems Corporate Summary
Table 46. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product Offerings
Table 47. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 48. Corium International, Inc Corporate Summary
Table 49. Corium International, Inc Transmucosal Drug Delivery Product Offerings
Table 50. Corium International, Inc Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 51. DURECT Corporation Corporate Summary
Table 52. DURECT Corporation Transmucosal Drug Delivery Product Offerings
Table 53. DURECT Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 54. Generex Biotechnology Corporation Corporate Summary
Table 55. Generex Biotechnology Corporation Transmucosal Drug Delivery Product Offerings
Table 56. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 57. Inovio Pharmaceuticals, Inc. Corporate Summary
Table 58. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 59. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 60. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Corporate Summary
Table 61. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product Offerings
Table 62. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 63. MedPharm LTD Corporate Summary
Table 64. MedPharm LTD Transmucosal Drug Delivery Product Offerings
Table 65. MedPharm LTD Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 66. Mylan, Inc. Corporate Summary
Table 67. Mylan, Inc. Transmucosal Drug Delivery Product Offerings
Table 68. Mylan, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 69. Nemaura Pharma Ltd Corporate Summary
Table 70. Nemaura Pharma Ltd Transmucosal Drug Delivery Product Offerings
Table 71. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 72. Nitto Denko Corporation Corporate Summary
Table 73. Nitto Denko Corporation Transmucosal Drug Delivery Product Offerings
Table 74. Nitto Denko Corporation Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 75. Noven Pharmaceuticals, Inc. Corporate Summary
Table 76. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product Offerings
Table 77. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 78. Pantec Biosolutions AG Corporate Summary
Table 79. Pantec Biosolutions AG Transmucosal Drug Delivery Product Offerings
Table 80. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 81. Tapemark Corporate Summary
Table 82. Tapemark Transmucosal Drug Delivery Product Offerings
Table 83. Tapemark Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 84. tesa Labtec GmbH Corporate Summary
Table 85. tesa Labtec GmbH Transmucosal Drug Delivery Product Offerings
Table 86. tesa Labtec GmbH Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 87. TEVA Pharmaceutical Industries Ltd. Corporate Summary
Table 88. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product Offerings
Table 89. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 90. Zosano Pharma Corporate Summary
Table 91. Zosano Pharma Transmucosal Drug Delivery Product Offerings
Table 92. Zosano Pharma Transmucosal Drug Delivery Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Transmucosal Drug Delivery Segment by Type
Figure 2. Transmucosal Drug Delivery Segment by Application
Figure 3. Global Transmucosal Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Transmucosal Drug Delivery Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Transmucosal Drug Delivery Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2020
Figure 8. By Type - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 9. By Application - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 10. By Region - Global Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 11. By Country - North America Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 12. US Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 16. Germany Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 17. France Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 24. China Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 28. India Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 30. Brazil Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Transmucosal Drug Delivery Revenue Market Share, 2016-2027
Figure 33. Turkey Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Transmucosal Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 37. 3M Pharmaceuticals Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Acrux Limited Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. ALZA Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Antares Pharma, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Apricus BioSciences, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Aveva Drug Delivery Systems Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Corium International, Inc Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. DURECT Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Generex Biotechnology Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. MedPharm LTD Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Mylan, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Nemaura Pharma Ltd Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Nitto Denko Corporation Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Pantec Biosolutions AG Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Tapemark Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. tesa Labtec GmbH Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Zosano Pharma Transmucosal Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs